.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,342,515

« Back to Dashboard

Summary for Patent: 6,342,515

Title: Remedy for neurodegenerative diseases
Abstract:The present invention provides a medicament for neurodegenerative diseases comprising zonisamide or an alkali metal salt thereof as an active ingredient. The present medicament can be used in the prevention and treatment of neurodegenerative diseases such as Parkinson's disease, Huntington's disease, choreic syndrome and dystonic syndrome in mammals (including human).
Inventor(s): Masuda; Yoshinobu (Katano, JP), Ochi; Yoshiaki (Sanda, JP)
Assignee: Dainippon Pharmaceutical Co., Ltd. (Osaka-fu, JP)
Application Number:09/582,433
Patent Claim Types:
see list of patent claims
Use;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 3rd percentile
Forward Citations: 0th percentile

No matches for this query

Premature patent expiration for: 6,342,515

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
6,342,515 January 29, 2014

Foreign Priority and PCT Information for Patent: 6,342,515

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan9-369313Dec 26, 1997
PCT Information
PCT FiledDecember 21, 1998PCT Application Number:PCT/JP98/05757
PCT Publication Date:July 08, 1999PCT Publication Number: WO99/33465

International Patent Family for Patent: 6,342,515

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria297204► subscribe
Canada2317044► subscribe
China1149084► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc